| Literature DB >> 27736893 |
Steffi Kopprasch1, Srirangan Dheban2, Kai Schuhmann3, Aimin Xu4, Klaus-Martin Schulte5, Charmaine J Simeonovic6, Peter E H Schwarz1, Stefan R Bornstein1, Andrej Shevchenko3, Juergen Graessler1.
Abstract
OBJECTIVE: Glucolipotoxicity is a major pathophysiological mechanism in the development of insulin resistance and type 2 diabetes mellitus (T2D). We aimed to detect subtle changes in the circulating lipid profile by shotgun lipidomics analyses and to associate them with four different insulin sensitivity indices.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27736893 PMCID: PMC5063331 DOI: 10.1371/journal.pone.0164173
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Baseline clinical data, glycemic status, and conventional lipid parameters of NGT, IGT, and diabetic (T2D) male subjects.
| Parameter | NGT | IGT | T2D | p-values | ||
|---|---|---|---|---|---|---|
| (n = 33) | (n = 32) | (n = 25) | ||||
| Age (years) | 54±2 | 60±2 | 63±2 | 0.192 | 0.017 | 0.861 |
| BMI (kg/m²) | 28.3±0.8 | 29.0±0.7 | 30.4±0.7 | 1.000 | 0.165 | 0.597 |
| WHR | 0.94±0.01 | 0.97±0.01 | 1.00±0.01 | 0.243 | 0.001 | 0.122 |
| Blood pressure (mmHg) | ||||||
| systolic | 131±3 | 143±3 | 151±4 | 0.016 | 0.000 | 0.430 |
| diastolic | 78±1 | 85±2 | 85±2 | 0.038 | 0.074 | 1.000 |
| CRP (mg/l) | 1.3±0.2 | 1.6±0.2 | 2.0±0.3 | 1.000 | 0.100 | 0.649 |
| Leukocytes (GPt/l) | 5.5±0.3 | 5.8±0.3 | 5.8±0.2 | 1.000 | 1.000 | 1.000 |
| HbA1C (mmol/mol) | 36±1 | 40±1 | 44±1 | 0.011 | 0.000 | 0.010 |
| Plasma glucose (mmol/l) | ||||||
| 0 min | 5.24±0.08 | 5.73±0.10 | 6.81±0.18 | 0.009 | 0.000 | 0.000 |
| 120 min | 5.06±0.21 | 8.95±0.14 | 12.06±0.49 | 0.000 | 0.000 | 0.000 |
| Insulin (pmol/l) | ||||||
| 0 min | 79.9±18.0 | 79.7±10.3 | 142.4±18.3 | 1.000 | 0.000 | 0.024 |
| 120 min | 213.6±35.5 | 647.3±85.4 | 774.2±105.4 | 0.000 | 0.000 | 0.078 |
| C-peptide (pmol/l) | ||||||
| 0 min | 841±71 | 870±43 | 1377±117 | 0.689 | 0.000 | 0.000 |
| 120 min | 2200±166 | 3674±237 | 3979±279 | 0.000 | 0.000 | 1.000 |
| GSI | 0.89±0.15 | 0.63±0.11 | 0.29±0.05 | 0.379 | 0.004 | 0.186 |
| ISI | 6.93±0.76 | 3.08±0.14 | 2.19±0.11 | 0.000 | 0.000 | 0.655 |
| DI | 9710±1648 | 2804±321 | 2151±267 | 0.000 | 0.000 | 1.000 |
| HOMA-IR | 2.81±0.68 | 2.97±0.38 | 3.81±0.39 | 1.000 | 0.001 | 0.002 |
| Total cholesterol (mmol/l) | 4.39±0.11 | 5.22±0.17 | 5.54±0.21 | 0.001 | 0.000 | 0.597 |
| Triglycerides (mmol/l) | 1.06±0.07 | 1.92±0.24 | 2.28±0.29 | 0.010 | 0.000 | 0.731 |
| Free fatty acids (mmol/l) | 0.40±0.03 | 0.49±0.03 | 0.61±0.17 | 0.035 | 0.000 | 0.018 |
| HDL cholesterol (mmol/l) | 1.40±0.05 | 1.28±0.06 | 1.19±0.09 | 0.340 | 0.034 | 0.849 |
| LDL cholesterol (mmol/l) | 2.58±0.09 | 3.19±0.14 | 3.48±0.20 | 0.005 | 0.000 | 0.447 |
Data are given as means ± SEM. Statistics by univariate analysis of variance with post-hoc Bonferroni test.
a–glucose insulin sensitivity index
b–insulin sensitivity index
c–disposition index
d–homeostasis model of insulin resistance
0 min and 120 min represents values before and after oral glucose challenge
Circulating lipid status of NGT, IGT, and diabetic (T2D) male subjects.
| Parameter | NGT | IGT | T2D | p-values | ||
|---|---|---|---|---|---|---|
| (n = 33) | (n = 32) | (n = 25) | ||||
| Triacylglycerols (TAG) | 1065±87 | 1782±218 | 2237±323 | 0.045 | 0.001 | 0.440 |
| Diacylglycerols (DAG) | 39.6± | 63.2±7.1 | 73.9±9.0 | 0.026 | 0.001 | 0.788 |
| Cholesterylesters (CE) | 3771±100 | 4330±122 | 4584±173 | 0.006 | 0.000 | 0.542 |
| Ceramides (Cer) | 4.95±0.26 | 6.22±0.37 | 7.31±0.47 | 0.032 | 0.000 | 0.132 |
| Phosphatidylcholines (PC) | 1074±26 | 1291±49 | 1377±45 | 0.000 | 0.000 | 0.455 |
| Lysophosphatidylcholines (LPC) | 273±7 | 302±15 | 290±11 | 0.203 | 0.944 | 1.000 |
| Lysophosphatidyl-ethanolamines (LPE) | 9.2±0.4 | 10.4±0.7 | 10.0±0.6 | 0.350 | 1.000 | 1.000 |
| Ether-linked phosphatidyl-cholines (PC O-) | 48.7±1.9 | 52.7±1.6 | 51.3±1.5 | 0.264 | 0.879 | 1.000 |
| Phosphatidylinositols (PI) | 37.2±1.4 | 49.0±2.8 | 53.6±2.9 | 0.001 | 0.000 | 0.573 |
| Phosphatidylethanolamines (PE) | 14.0±0.8 | 23.7±2.4 | 27.1±2.4 | 0.001 | 0.000 | 0.694 |
| Ether-linked Phosphatidyl-ethanolamines (PE O-) | 25.4±1.6 | 28.3±1.0 | 28.6±1.2 | 0.351 | 0.317 | 1.000 |
| Sphingomyelins (SM) | 352±8 | 372±9 | 389±15 | 0.489 | 0.050 | 0.802 |
| Free cholesterol (Chol) | 1047±32 | 1239±50 | 1350±62 | 0.011 | 0.000 | 0.340 |
Data are given as means ± SEM. P-values were adjusted by means of Benjamini-Hochberg procedure.
Fig 1Relative errors of insulin sensitivity indices HOMA-IR, ISI, GSI, and DI explained by lipid species and age, BMI, WHR and systolic blood pressure.
Three different selection methods were applied: LASSO, Random Forests (RF), and support vector regression (SVR). Data are presented as boxplots plus median.
Fig 2Spearman rank correlation of TAG species with different total acyl chain carbon numbers and double bond content and the insulin sensitivity indices HOMA-IR and ISI.
Desaturase activities.
| A) | Enzyme activity | p-value | ||||
|---|---|---|---|---|---|---|
| NGT | IGT | T2D | NGT v. IGT | NGT v. T2D | IGT v. T2D | |
| 22.94 | 19.41 | 17.50 | NS | NS | NS | |
| 0.364 | 0.523 | 0.487 | 0.001 | 0.002 | NS | |
| 0.367 | 0.593 | 0.534 | 0.006 | 0.002 | NS | |
Correlation coefficients of desaturase activities to insulin sensitivity indices.
| B) | Spearman rho correlation coefficients to sensitivity indices (significance) | |||
|---|---|---|---|---|
| HOMA-IR | GSI | ISI | DI | |
| -0.268 | 0.267 | 0.209 | 0.080 | |
| (0.011) | (0.011) | (0.050) | (0.455) | |
| 0.244 | -0.162 | -0.426 | -0.374 | |
| (0.021) | (0.127) | (0.000) | (0.000) | |
| 0.273 | -0.223 | -0.373 | -0.297 | |
| (0.010) | (0.035) | (0.000) | (0.005) | |
Fig 3Strength and direction of LASSO regression coefficients for the insulin sensitivity indices HOMA-IR, GSI, and ISI.